Evaxion AS (EVAX)
3.20
+0.02
(+0.63%)
USD |
NASDAQ |
Oct 02, 16:00
3.25
+0.05
(+1.56%)
After-Hours: 20:00
Evaxion Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 61.64% |
| June 30, 2025 | -13.06K% |
| March 31, 2025 | |
| December 31, 2024 | -2.98K% |
| Date | Value |
|---|---|
| September 30, 2024 | -64.14% |
| June 30, 2024 | -4.02K% |
| March 31, 2024 | |
| December 31, 2023 | -6.20K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -85.60% |
| Cellectis SA | -417.3% |
| Akari Therapeutics Plc | -- |
| DBV Technologies SA | -- |
| Ascendis Pharma A/S | 61.00% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.35% |
| Return on Assets | -35.12% |
| Return on Invested Capital | -49.06% |
| Return on Net Operating Assets | -248.5% |